Patrangsit Healthcare Group PCL (BKK:PHG) Debt-to-EBITDA : 0.04 (As of Jun. 2026) — 69% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:PHG Patrangsit Healthcare Group PCL BKK:PHG
48 GF Score
Price ฿10.20
GF Value ฿15.67
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Patrangsit Healthcare Group PCL Debt-to-EBITDA?

Patrangsit Healthcare Group PCL BKK:PHG 48 Debt-to-EBITDA is 0.04 as of Jun. 2026, which is 69% below its 10-year median of 0.13. GuruFocus rates BKK:PHG with a GF Score™ of 48/100 and a GF Value™ of ฿15.67 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Patrangsit Healthcare Group PCL ranks better than 97.69% on this metric.

Debt-to-EBITDA measures a company's ability to pay off its debt.

Patrangsit Healthcare Group PCL's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ฿4 Mil. Patrangsit Healthcare Group PCL's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ฿8 Mil. Patrangsit Healthcare Group PCL's annualized EBITDA for the quarter that ended in Jun. 2026 was ฿313 Mil. Patrangsit Healthcare Group PCL's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 was 0.04.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Patrangsit Healthcare Group PCL's Debt-to-EBITDA or its related term are showing as below:

BKK:PHG' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.02   Med: 0.13   Max: 0.81
Current: 0.03

During the past 5 years, the highest Debt-to-EBITDA Ratio of Patrangsit Healthcare Group PCL was 0.81. The lowest was 0.02. And the median was 0.13.

BKK:PHG's Debt-to-EBITDA is ranked better than
97.69% of 477 companies
in the Healthcare Providers & Services industry
Industry Median: 2.18 vs BKK:PHG: 0.03

Patrangsit Healthcare Group PCL  (BKK:PHG) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Patrangsit Healthcare Group PCL Debt-to-EBITDA Related Terms


Patrangsit Healthcare Group PCL Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Patrangsit Healthcare Group PCL's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Patrangsit Healthcare Group PCL Debt-to-EBITDA Chart

Patrangsit Healthcare Group PCL Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-EBITDA
0.81 0.74 0.13 0.02 0.02

Patrangsit Healthcare Group PCL Quarterly Data
Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.02 0.03 0.04

BKK:PHG vs HCA, THC, EHC: Debt-to-EBITDA Comparison

For the Medical Care Facilities subindustry, Patrangsit Healthcare Group PCL's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Patrangsit Healthcare Group PCL Debt-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Patrangsit Healthcare Group PCL's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Patrangsit Healthcare Group PCL's Debt-to-EBITDA falls into.


BKK:PHG
48GF Score
Patrangsit Healthcare Group PCL BKK:PHG
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Patrangsit Healthcare Group PCL Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Patrangsit Healthcare Group PCL's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.534 + 5.024) / 493.483
=0.02

Patrangsit Healthcare Group PCL's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.772 + 7.568) / 312.5
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of 0.04 mean?
Patrangsit Healthcare Group PCL (BKK:PHG) has a Debt-to-EBITDA of 0.04 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Patrangsit Healthcare Group PCL. This is 69% below median its historical median of 0.13. Over the past decade, Patrangsit Healthcare Group PCL's Debt-to-EBITDA has ranged from 0.02 to 0.81. According to the industry distribution chart, Patrangsit Healthcare Group PCL ranks #11 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 2.3%.
Is Patrangsit Healthcare Group PCL's Debt-to-EBITDA too high?
Patrangsit Healthcare Group PCL's current Debt-to-EBITDA of 0.04 is 69% below median its 10-year median of 0.13. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 0.81. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.18. Patrangsit Healthcare Group PCL's value of 0.04 is 98.2% below this industry median. Based on the distribution chart, Patrangsit Healthcare Group PCL ranks #11 out of 477 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Patrangsit Healthcare Group PCL has a GF Score™ of 48/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Patrangsit Healthcare Group PCL's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Patrangsit Healthcare Group PCL ranks #11 out of 477 companies for Debt-to-EBITDA. This places Patrangsit Healthcare Group PCL in the top 2% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.18. Patrangsit Healthcare Group PCL's value of 0.04 is 98.2% below this benchmark. Historically, Patrangsit Healthcare Group PCL's own Debt-to-EBITDA has ranged from 0.02 to 0.81 over the past decade. While the company's 10-year median is 0.13 vs. the industry median of 2.18, Patrangsit Healthcare Group PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.18, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Patrangsit Healthcare Group PCL's current Debt-to-EBITDA of 0.04 is 98.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Patrangsit Healthcare Group PCL. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Patrangsit Healthcare Group PCL's current Debt-to-EBITDA is 0.04, which is 69% below median its own 10-year median of 0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Patrangsit Healthcare Group PCL stock overvalued right now?
Based on GuruFocus' analysis, Patrangsit Healthcare Group PCL (BKK:PHG) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿15.67, compared to a current price of ฿10.20 — trading 34.9% below its estimated fair value. The current Debt-to-EBITDA is 0.04, which is 69% below median its 10-year median of 0.13 and 98.2% below the Healthcare Providers & Services industry median of 2.18. Patrangsit Healthcare Group PCL's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Patrangsit Healthcare Group PCL (BKK:PHG), the current Debt-to-EBITDA is 0.04 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Patrangsit Healthcare Group PCL (BKK:PHG) Overvalued in 2026?

Based on GuruFocus' analysis, Patrangsit Healthcare Group PCL stock appears to be undervalued. The current stock price of ฿10.20 is trading 34.9% below its estimated GF Value™ of ฿15.67. GuruFocus considers Patrangsit Healthcare Group PCL to be Significantly Undervalued.

Key valuation signals for BKK:PHG:

  • Debt-to-EBITDA: 0.04 (69% below median its 10-year median of 0.13)
  • GF Value™: ฿15.67 vs. price of ฿10.20 (34.9% below fair value)
  • GF Score™: 48/100 with 2 warning signs
  • Industry Position: 98.2% below the Healthcare Providers & Services median (#11 of 477)

No single metric tells the full story. See the BKK:PHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Patrangsit Healthcare Group PCL Business Description

Address 733/345, 733/359 Moo 8, Phahonyothin Road, Tambon Khu Khot, Amphoe Lam Luk Ka, Pathum Thani, Bangkok, THA, 12130
Patrangsit Healthcare Group PCL engages in the operations of the hospital business. The company's services include medical services, wardroom, health insurance customer services, corporate customer services and international services. It operates in one main reportable operating segment, which is hospital business and operates in one geographical area, which is Thailand.
48GF Score

Get the complete analysis for BKK:PHG

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿10.20
Price
฿15.67
GF Value